Lucy M Schmidt, MD
Dermatology · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Schmidt’s office at (650) 344-4142 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence C33449 · Current
Licensed to practise in California · since 1971 · expires 2027-05-31 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$65,115
Medicare paid this office $65,115 for 593 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Destruction of precancer skin growth, 1 growth | 314 | $20,968 | $49 |
| Short return visit | 246 | $13,455 | $43 |
| Destruction of precancer skin growth, 2-14 growths | 225 | $5,336 | $6 |
| Biopsy of related skin growth, first growth | 52 | $4,833 | $83 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $3,068 | $133 |
See all 11 services
| Destruction of precancer skin growth, 1 growth | 314 | $20,968 | $49 |
| Short return visit | 246 | $13,455 | $43 |
| Destruction of precancer skin growth, 2-14 growths | 225 | $5,336 | $6 |
| Biopsy of related skin growth, first growth | 52 | $4,833 | $83 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $3,068 | $133 |
| New patient visit (15+ min) | 58 | $2,680 | $46 |
| Punch biopsy, first skin growth | 15 | $1,517 | $101 |
| Removal of skin tag, 1-15 skin tags | 21 | $1,504 | $63 |
| Injection into skin growth, 1-7 growths | 28 | $1,326 | $37 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 59 | $1,121 | $18 |
| Biopsy of related skin growth, each additional growth | 14 | $821 | $46 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 26 | More than 78% of doctors who do this |
| Removal of skin lesions | 794 | More than 91% of doctors who do this |
| Removal or shaving of skin growth | 27 | More than 74% of doctors who do this |
| Skin biopsy | 86 | More than 74% of doctors who do this |
Who their Medicare patients are
593 Original Medicare patients in 2024. Average age 76 · Women 61% · Also on Medicaid 0% · Health risk score 0.85. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 61% · Coronary heart disease 18% · Cancer 17% · Diabetes 16% · Chronic kidney disease 15% · Atrial fibrillation 12% · Heart failure 9% · Depression 9% · COPD 6% · Stroke 4% · Dementia 3%.
The office billed $116,085, Medicare allowed $99,617 and paid $65,115; for 2,032 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 593 | 2,032 | 76 | 0.85 | $116,085 | $65,115 |
| 2023 | 655 | 2,250 | 76 | 0.82 | $124,388 | $79,140 |
| 2022 | 655 | 2,320 | 76 | 0.82 | $126,997 | $76,727 |
| 2021 | 602 | 2,091 | 76 | 0.77 | $114,609 | $72,598 |
| 2020 | 568 | 1,856 | 76 | 0.91 | $110,897 | $63,242 |
| 2019 | 773 | 2,736 | 76 | 0.91 | $144,164 | $86,754 |
| 2018 | 729 | 2,759 | 76 | 0.94 | $148,785 | $80,216 |
| 2017 | 707 | 2,649 | 76 | 0.94 | $159,338 | $77,373 |
| 2016 | 722 | 2,742 | 76 | 0.94 | $174,236 | $88,383 |
| 2015 | 794 | 2,819 | 76 | 0.93 | $182,976 | $94,188 |
| 2014 | 784 | 2,780 | 76 | 0.92 | $185,253 | $103,580 |
| 2013 | 725 | 2,695 | 76 | 0.88 | $169,893 | $101,206 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Destruction of precancer skin growth, 1 growth | 324 | $24,749 | $55 |
| Short return visit | 268 | $15,430 | $47 |
| Destruction of precancer skin growth, 2-14 growths | 236 | $6,791 | $6 |
| Biopsy of related skin growth, first growth | 58 | $6,276 | $97 |
| New patient visit (15+ min) | 88 | $4,597 | $52 |
| Destruction of precancer skin growth, 15 or more growths | 18 | $4,343 | $167 |
| Removal of skin tag, 1-15 skin tags | 20 | $1,389 | $69 |
| Punch biopsy, first skin growth | 11 | $1,385 | $126 |
| Destruction of skin growth, 1-14 growths | 11 | $1,291 | $99 |
| Injection into skin growth, 1-7 growths | 23 | $1,130 | $38 |
| New patient visit (30+ min) | 11 | $1,050 | $95 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $908 | $20 |
2022: 12 services
| Destruction of precancer skin growth, 1 growth | 328 | $22,323 | $50 |
| Short return visit | 275 | $15,674 | $45 |
| Destruction of precancer skin growth, 2-14 growths | 242 | $6,450 | $6 |
| Biopsy of related skin growth, first growth | 51 | $5,573 | $91 |
| New patient visit (15+ min) | 90 | $4,572 | $51 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $3,543 | $161 |
| New patient visit (30+ min) | 19 | $1,767 | $93 |
| Punch biopsy, first skin growth | 14 | $1,664 | $119 |
| Short return visit (20+ min) | 23 | $1,457 | $63 |
| Injection into skin growth, 1-7 growths | 23 | $1,040 | $39 |
| Removal of skin tag, 1-15 skin tags | 19 | $922 | $49 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 39 | $742 | $18 |
2021: 11 services
| Destruction of precancer skin growth, 1 growth | 300 | $20,727 | $53 |
| Short return visit | 265 | $15,907 | $46 |
| Destruction of precancer skin growth, 2-14 growths | 218 | $6,016 | $6 |
| Biopsy of related skin growth, first growth | 52 | $5,155 | $95 |
| Destruction of precancer skin growth, 15 or more growths | 26 | $4,799 | $145 |
| New patient visit (15+ min) | 68 | $3,455 | $51 |
| Punch biopsy, first skin growth | 16 | $2,044 | $120 |
| New patient visit (30+ min) | 13 | $1,151 | $89 |
| Short return visit (20+ min) | 17 | $1,041 | $61 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 39 | $873 | $21 |
| Removal of skin tag, 1-15 skin tags | 13 | $749 | $58 |
2020: 12 services
| Destruction of precancer skin growth, 1 growth | 260 | $16,184 | $47 |
| Short return visit | 220 | $9,313 | $33 |
| Biopsy of related skin growth, first growth | 50 | $5,070 | $86 |
| Destruction of precancer skin growth, 15 or more growths | 23 | $4,055 | $123 |
| Destruction of precancer skin growth, 2-14 growths | 190 | $3,843 | $5 |
| New patient visit (15+ min) | 68 | $3,226 | $47 |
| Punch biopsy, first skin growth | 22 | $2,524 | $105 |
| Destruction of skin growth, 1-14 growths | 17 | $2,326 | $86 |
| Injection into skin growth, 1-7 growths | 23 | $1,317 | $39 |
| Short return visit (20+ min) | 13 | $954 | $64 |
| Removal of skin tag, 1-15 skin tags | 14 | $882 | $63 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 44 | $816 | $16 |
2019: 14 services
| Destruction of precancer skin growth, 1 growth | 404 | $26,448 | $49 |
| Short return visit | 300 | $13,755 | $34 |
| Destruction of precancer skin growth, 2-14 growths | 274 | $5,885 | $5 |
| New patient visit (15+ min) | 91 | $5,149 | $57 |
| Destruction of precancer skin growth, 15 or more growths | 26 | $4,566 | $127 |
| Biopsy of related skin growth, first growth | 45 | $4,202 | $88 |
| Punch biopsy, first skin growth | 30 | $3,273 | $106 |
| New patient visit (30+ min) | 32 | $2,348 | $73 |
| Short return visit (20+ min) | 30 | $1,747 | $56 |
| Destruction of skin growth, 1-14 growths | 17 | $1,574 | $87 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $1,147 | $20 |
| Removal of skin tag, 1-15 skin tags | 17 | $1,079 | $63 |
| Injection into skin growth, 1-7 growths | 22 | $977 | $38 |
| New patient visit (10+ min) | 11 | $377 | $34 |
2018: 13 services
| Destruction of precancer skin growth, 1 growth | 406 | $26,930 | $49 |
| Short return visit | 270 | $12,574 | $33 |
| Biopsy of single growth of skin and/or tissue | 63 | $6,146 | $90 |
| Destruction of precancer skin growth, 15 or more growths | 31 | $5,905 | $118 |
| Destruction of precancer skin growth, 2-14 growths | 287 | $5,710 | $4 |
| New patient visit (15+ min) | 78 | $4,461 | $57 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $2,735 | $210 |
| Destruction of skin growth, 1-14 growths | 21 | $1,836 | $77 |
| Short return visit (20+ min) | 28 | $1,277 | $46 |
| New patient visit (30+ min) | 20 | $1,225 | $61 |
| Injection into skin growth, 1-7 growths | 22 | $1,120 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $921 | $17 |
| Biopsy of each additional growth of skin and/or tissue | 12 | $559 | $27 |
2017: 11 services
| Destruction of precancer skin growth, 1 growth | 376 | $24,730 | $49 |
| Short return visit | 258 | $11,091 | $33 |
| Destruction of precancer skin growth, 2-14 growths | 267 | $6,096 | $4 |
| Biopsy of single growth of skin and/or tissue | 62 | $5,560 | $84 |
| Destruction of precancer skin growth, 15 or more growths | 35 | $5,209 | $111 |
| New patient visit (15+ min) | 67 | $3,512 | $52 |
| New patient visit (30+ min) | 15 | $1,369 | $91 |
| Destruction of skin growth, 1-14 growths | 12 | $1,225 | $87 |
| Short return visit (20+ min) | 30 | $1,207 | $39 |
| Injection into skin growth, 1-7 growths | 21 | $1,059 | $39 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 51 | $894 | $17 |
2016: 13 services
| Destruction of precancer skin growth, 1 growth | 424 | $30,364 | $51 |
| Short return visit | 263 | $12,532 | $34 |
| Biopsy of single growth of skin and/or tissue | 71 | $6,982 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 301 | $6,514 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 30 | $5,173 | $129 |
| Short return visit (20+ min) | 61 | $2,951 | $47 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $2,911 | $224 |
| New patient visit (15+ min) | 40 | $2,073 | $52 |
| New patient visit (30+ min) | 21 | $1,714 | $82 |
| Destruction of skin growth, 1-14 growths | 11 | $1,342 | $96 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 50 | $818 | $15 |
| Injection into skin growth, 1-7 growths | 11 | $782 | $43 |
| Biopsy of each additional growth of skin and/or tissue | 11 | $415 | $30 |
2015: 14 services
| Destruction of precancer skin growth, 1 growth | 436 | $31,068 | $53 |
| Short return visit | 310 | $13,863 | $34 |
| Biopsy of single growth of skin and/or tissue | 81 | $8,287 | $92 |
| Destruction of precancer skin growth, 2-14 growths | 296 | $6,381 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 24 | $4,340 | $124 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 13 | $2,934 | $196 |
| New patient visit (30+ min) | 33 | $2,885 | $87 |
| Short return visit (20+ min) | 47 | $2,822 | $56 |
| New patient visit (15+ min) | 46 | $2,781 | $60 |
| Destruction of skin growth, 1-14 growths | 14 | $1,760 | $104 |
| Injection into skin growth, 1-7 growths | 20 | $1,435 | $42 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 64 | $1,141 | $17 |
| Removal of skin tag, 1-15 skin tags | 12 | $857 | $71 |
| Biopsy of each additional growth of skin and/or tissue | 12 | $386 | $30 |
2014: 12 services
| Destruction of precancer skin growth, 1 growth | 430 | $33,279 | $58 |
| Short return visit | 308 | $14,111 | $35 |
| Destruction of precancer skin growth, 2-14 growths | 293 | $11,381 | $9 |
| Biopsy of single growth of skin and/or tissue | 82 | $7,764 | $85 |
| Destruction of precancer skin growth, 15 or more growths | 29 | $5,046 | $133 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 15 | $3,086 | $206 |
| New patient visit (30+ min) | 35 | $2,824 | $81 |
| Short return visit (20+ min) | 48 | $2,738 | $57 |
| New patient visit (15+ min) | 44 | $2,596 | $59 |
| Injection into skin growth, 1-7 growths | 24 | $2,435 | $45 |
| Destruction of skin growth, 1-14 growths | 15 | $1,764 | $98 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 70 | $1,373 | $18 |
2013: 12 services
| Destruction of precancer skin growth, 1 growth | 403 | $36,398 | $68 |
| Short return visit | 285 | $13,565 | $37 |
| Biopsy of single growth of skin and/or tissue | 100 | $10,075 | $96 |
| Destruction of precancer skin growth, 2-14 growths | 288 | $7,285 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 27 | $4,045 | $130 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 16 | $3,577 | $210 |
| Short return visit (20+ min) | 59 | $3,429 | $53 |
| New patient visit (30+ min) | 31 | $2,826 | $91 |
| New patient visit (15+ min) | 31 | $2,029 | $65 |
| Injection into skin growth, 1-7 growths | 21 | $1,950 | $49 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 69 | $1,411 | $18 |
| Removal of skin tag, 1-15 skin tags | 12 | $897 | $75 |
Medicaid work
$4,214 in 2019
Medicaid paid $4,214 for 76 billed services this clinician did in 2019, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 64 | $3,024 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 12 | $1,191 |
| 2019 | 76 | 2 | 15 | $4,214 |
Drugs they prescribed that Part D paid
$186,169
Pharmacies billed $186,169 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 877) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
833 generic and 44 brand-name prescriptions · $186,169 in drug cost · 72 antibiotic prescriptions to 33 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Betamethasone Dipropionate | 95 | $3,877 | $41 |
| Fluorouracil | 24 | $1,470 | $61 |
| Fluocinolone Acetonide | 21 | $1,470 | $70 |
| Clobetasol Propionate | 51 | $1,393 | $27 |
| Metronidazole | 33 | $1,319 | $40 |
See all 21 drugs
| Betamethasone Dipropionate | 95 | $3,877 | $41 |
| Fluorouracil | 24 | $1,470 | $61 |
| Fluocinolone Acetonide | 21 | $1,470 | $70 |
| Clobetasol Propionate | 51 | $1,393 | $27 |
| Metronidazole | 33 | $1,319 | $40 |
| Erythromycin | 12 | $1,158 | $96 |
| Triamcinolone Acetonide | 117 | $1,049 | $9 |
| Fluocinonide | 27 | $945 | $35 |
| Desonide | 38 | $910 | $24 |
| Doxycycline Hyclate | 32 | $840 | $26 |
| Mometasone Furoate | 45 | $766 | $17 |
| Imiquimod | 29 | $698 | $24 |
| Methotrexate | 23 | $567 | $25 |
| Ciclopirox | 40 | $475 | $12 |
| Valacyclovir | 23 | $458 | $20 |
| Clindamycin Phosphate | 17 | $367 | $22 |
| Mupirocin | 51 | $364 | $7 |
| Cephalexin | 20 | $155 | $8 |
| Ketoconazole | 14 | $152 | $11 |
| Minoxidil | 13 | $98 | $8 |
| Prednisone | 19 | $44 | $2 |
Year by year
| 2024 | 877 | 315 | 0% (0) | 5% | $186,169 |
| 2023 | 854 | 314 | 0% (0) | 9% | $219,647 |
| 2022 | 835 | 298 | 0% (0) | None | $215,668 |
| 2021 | 775 | 277 | 0% (0) | 13% | $160,852 |
| 2020 | 904 | 295 | 0% (0) | 11% | $180,184 |
| 2019 | 851 | 324 | 0% (0) | 13% | $177,394 |
| 2018 | 880 | 309 | 0% (0) | 12% | $181,939 |
| 2017 | 785 | 292 | 0% (0) | 13% | $159,150 |
| 2016 | 759 | 269 | None | 15% | $133,171 |
| 2015 | 753 | 287 | 0% (0) | 19% | $120,358 |
| 2014 | 822 | 305 | 0% (0) | None | $98,741 |
| 2013 | 674 | 261 | None | None | $55,393 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 19 drugs
| Humira(Cf) | 11 | $83,039 | $7,549 |
| Betamethasone Dipropionate | 97 | $4,809 | $50 |
| Metronidazole | 37 | $2,397 | $65 |
| Doxycycline Hyclate | 36 | $1,337 | $37 |
| Clobetasol Propionate | 45 | $1,273 | $28 |
| Fluocinonide | 35 | $1,177 | $34 |
| Triamcinolone Acetonide | 152 | $1,134 | $7 |
| Fluorouracil | 13 | $1,070 | $82 |
| Imiquimod | 18 | $947 | $53 |
| Mometasone Furoate | 32 | $614 | $19 |
| Ciclopirox | 38 | $610 | $16 |
| Mupirocin | 46 | $540 | $12 |
| Desonide | 20 | $529 | $26 |
| Methotrexate | 11 | $415 | $38 |
| Valacyclovir | 12 | $383 | $32 |
| Ketoconazole | 19 | $347 | $18 |
| Cephalexin | 37 | $340 | $9 |
| Alclometasone Dipropionate | 16 | $291 | $18 |
| Clindamycin Phosphate | 15 | $268 | $18 |
2022: 20 drugs
| Humira(Cf) | 22 | $143,127 | $6,506 |
| Betamethasone Dipropionate | 86 | $6,011 | $70 |
| Metronidazole | 37 | $2,516 | $68 |
| Clobetasol Propionate | 65 | $2,163 | $33 |
| Doxycycline Hyclate | 35 | $2,106 | $60 |
| Fluorouracil | 19 | $1,979 | $104 |
| Imiquimod | 13 | $1,498 | $115 |
| Prednisolone | 23 | $1,168 | $51 |
| Ciclopirox | 44 | $900 | $20 |
| Alclometasone Dipropionate | 23 | $687 | $30 |
| Fluocinonide | 12 | $649 | $54 |
| Methotrexate | 15 | $518 | $35 |
| Triamcinolone Acetonide | 89 | $510 | $6 |
| Mometasone Furoate | 23 | $491 | $21 |
| Mupirocin | 60 | $479 | $8 |
| Clindamycin Phosphate | 13 | $446 | $34 |
| Desonide | 14 | $416 | $30 |
| Ketoconazole | 21 | $322 | $15 |
| Cephalexin | 28 | $223 | $8 |
| Hydrocortisone | 23 | $149 | $6 |
2021: 21 drugs
| Humira(Cf) | 20 | $119,456 | $5,973 |
| Betamethasone Dipropionate | 112 | $7,345 | $66 |
| Calcipotriene | 18 | $4,503 | $250 |
| Metronidazole | 38 | $2,966 | $78 |
| Halobetasol Propionate | 24 | $1,992 | $83 |
| Doxycycline Hyclate | 24 | $1,181 | $49 |
| Fluorouracil | 11 | $1,069 | $97 |
| Clobetasol Propionate | 36 | $973 | $27 |
| Fluocinonide | 24 | $791 | $33 |
| Triamcinolone Acetonide | 115 | $694 | $6 |
| Ciclopirox | 41 | $509 | $12 |
| Imiquimod | 16 | $407 | $25 |
| Clindamycin Phosphate | 15 | $363 | $24 |
| Mupirocin | 32 | $362 | $11 |
| Ketoconazole | 23 | $361 | $16 |
| Mometasone Furoate | 14 | $308 | $22 |
| Alclometasone Dipropionate | 12 | $170 | $14 |
| Hydroxyzine | 17 | $135 | $8 |
| Cephalexin | 18 | $106 | $6 |
| Hydrocortisone | 18 | $86 | $5 |
| Finasteride | 11 | $71 | $6 |
2020: 25 drugs
| Humira(Cf) | 24 | $133,236 | $5,552 |
| Betamethasone Dipropionate | 100 | $6,358 | $64 |
| Calcipotriene | 11 | $3,390 | $308 |
| Fluorouracil | 19 | $3,326 | $175 |
| Halobetasol Propionate | 20 | $2,379 | $119 |
| Metronidazole | 32 | $2,354 | $74 |
| Clobetasol Propionate | 45 | $1,597 | $35 |
| Doxycycline Hyclate | 34 | $1,274 | $37 |
| Triamcinolone Acetonide | 146 | $1,169 | $8 |
| Desonide | 16 | $1,138 | $71 |
| Valacyclovir | 22 | $1,087 | $49 |
| Fluocinonide | 29 | $1,039 | $36 |
| Clindamycin Phosphate | 22 | $925 | $42 |
| Tetracycline | 13 | $792 | $61 |
| Acyclovir | 14 | $574 | $41 |
| Mupirocin | 42 | $532 | $13 |
| Ciclopirox | 41 | $532 | $13 |
| Alclometasone Dipropionate | 15 | $497 | $33 |
| Ketoconazole | 30 | $458 | $15 |
| Ciclopirox | 15 | $193 | $13 |
| Mometasone Furoate | 12 | $164 | $14 |
| Cephalexin | 23 | $140 | $6 |
| Hydrocortisone | 16 | $90 | $6 |
| Prednisone | 11 | $72 | $7 |
| Hydroxyzine | 14 | $63 | $4 |
2019: 21 drugs
| Humira(Cf) | 20 | $102,850 | $5,143 |
| Betamethasone Dipropionate | 87 | $5,624 | $65 |
| Metronidazole | 35 | $3,396 | $97 |
| Desonide | 30 | $2,523 | $84 |
| Valacyclovir | 35 | $2,484 | $71 |
| Clobetasol Propionate | 39 | $2,203 | $56 |
| Doxycycline Hyclate | 31 | $1,531 | $49 |
| Fluorouracil | 16 | $1,474 | $92 |
| Triamcinolone Acetonide | 137 | $1,159 | $8 |
| Fluocinonide | 29 | $1,034 | $36 |
| Imiquimod | 18 | $1,021 | $57 |
| Ciclopirox | 27 | $588 | $22 |
| Clindamycin Phosphate | 15 | $588 | $39 |
| Mupirocin | 41 | $494 | $12 |
| Mometasone Furoate | 20 | $457 | $23 |
| Acyclovir | 13 | $265 | $20 |
| Alclometasone Dipropionate | 12 | $231 | $19 |
| Ketoconazole | 13 | $189 | $15 |
| Fluconazole | 15 | $108 | $7 |
| Prednisone | 16 | $85 | $5 |
| Cephalexin | 15 | $67 | $4 |
2018: 23 drugs
| Humira | 26 | $124,930 | $4,805 |
| Clobetasol Propionate | 76 | $5,349 | $70 |
| Finacea | 12 | $4,069 | $339 |
| Betamethasone Dipropionate | 51 | $3,046 | $60 |
| Metronidazole | 29 | $2,530 | $87 |
| Fluorouracil | 24 | $2,333 | $97 |
| Imiquimod | 26 | $1,794 | $69 |
| Desonide | 21 | $1,784 | $85 |
| Famciclovir | 13 | $1,661 | $128 |
| Ciclopirox | 52 | $1,603 | $31 |
| Valacyclovir | 35 | $1,364 | $39 |
| Myorisan | 11 | $1,247 | $113 |
| Fluocinonide | 18 | $1,072 | $60 |
| Acyclovir | 14 | $993 | $71 |
| Triamcinolone Acetonide | 153 | $973 | $6 |
| Doxycycline Hyclate | 35 | $965 | $28 |
| Clindamycin Phosphate | 19 | $878 | $46 |
| Desoximetasone | 12 | $490 | $41 |
| Pentoxifylline | 13 | $400 | $31 |
| Mupirocin | 30 | $286 | $10 |
| Ketoconazole | 20 | $276 | $14 |
| Cephalexin | 29 | $200 | $7 |
| Hydrocortisone | 17 | $93 | $5 |
2017: 22 drugs
| Humira | 24 | $106,169 | $4,424 |
| Metronidazole | 47 | $4,450 | $95 |
| Clobetasol Propionate | 47 | $4,372 | $93 |
| Desonide | 27 | $3,669 | $136 |
| Betamethasone Dipropionate | 74 | $3,648 | $49 |
| Fluocinolone Acetonide | 18 | $2,544 | $141 |
| Fluorouracil | 18 | $2,105 | $117 |
| Desoximetasone | 17 | $1,664 | $98 |
| Tretinoin | 14 | $1,438 | $103 |
| Valacyclovir | 58 | $1,420 | $24 |
| Fluocinonide | 14 | $1,337 | $95 |
| Doxycycline Hyclate | 25 | $1,215 | $49 |
| Ciclopirox | 29 | $753 | $26 |
| Triamcinolone Acetonide | 98 | $581 | $6 |
| Pentoxifylline | 13 | $566 | $44 |
| Famciclovir | 12 | $557 | $46 |
| Acyclovir | 11 | $459 | $42 |
| Mupirocin | 24 | $237 | $10 |
| Cephalexin | 25 | $206 | $8 |
| Hydroxyzine | 18 | $179 | $10 |
| Hydrocortisone | 15 | $91 | $6 |
| Fluconazole | 12 | $34 | $3 |
2016: 25 drugs
| Humira | 17 | $66,405 | $3,906 |
| Clobetasol Propionate | 67 | $9,088 | $136 |
| Desonide | 40 | $5,979 | $149 |
| Fluorouracil | 17 | $5,750 | $338 |
| Fluocinolone Acetonide | 21 | $3,626 | $173 |
| Metronidazole | 34 | $2,992 | $88 |
| Zenatane | 12 | $2,903 | $242 |
| Betamethasone Dipropionate | 56 | $2,790 | $50 |
| Desoximetasone | 17 | $1,872 | $110 |
| Tretinoin | 11 | $1,605 | $146 |
| Acyclovir | 13 | $1,092 | $84 |
| Fluocinonide | 17 | $979 | $58 |
| Clindamycin Phosphate | 14 | $888 | $63 |
| Valacyclovir | 55 | $833 | $15 |
| Doxycycline Hyclate | 24 | $702 | $29 |
| Doxepin | 20 | $694 | $35 |
| Triamcinolone Acetonide | 65 | $534 | $8 |
| Ciclopirox | 21 | $481 | $23 |
| Hydrocortisone | 32 | $254 | $8 |
| Pentoxifylline | 14 | $243 | $17 |
| Cephalexin | 21 | $237 | $11 |
| Mometasone Furoate | 11 | $207 | $19 |
| Mupirocin | 14 | $154 | $11 |
| Prednisone | 13 | $114 | $9 |
| Fluconazole | 12 | $109 | $9 |
2015: 23 drugs
| Humira | 14 | $43,704 | $3,122 |
| Clobetasol Propionate | 108 | $21,029 | $195 |
| Desonide | 51 | $5,768 | $113 |
| Desoximetasone | 29 | $4,446 | $153 |
| Metronidazole | 36 | $3,988 | $111 |
| Imiquimod | 24 | $3,653 | $152 |
| Fluocinolone Acetonide | 20 | $3,289 | $164 |
| Betamethasone Dipropionate | 63 | $3,239 | $51 |
| Fluorouracil | 13 | $2,899 | $223 |
| Calcipotriene | 11 | $2,029 | $184 |
| Tretinoin | 14 | $1,430 | $102 |
| Acyclovir | 21 | $794 | $38 |
| Fluocinonide | 12 | $703 | $59 |
| Clindamycin Phosphate | 13 | $689 | $53 |
| Valacyclovir | 25 | $630 | $25 |
| Ciclopirox | 20 | $521 | $26 |
| Ketoconazole | 14 | $395 | $28 |
| Pentoxifylline | 15 | $276 | $18 |
| Mupirocin | 25 | $260 | $10 |
| Cephalexin | 25 | $243 | $10 |
| Mometasone Furoate | 13 | $237 | $18 |
| Triamcinolone Acetonide | 26 | $169 | $7 |
| Prednisone | 14 | $130 | $9 |
2014: 23 drugs
| Desonide | 69 | $11,404 | $165 |
| Clobetasol Propionate | 96 | $8,972 | $93 |
| Desoximetasone | 52 | $7,838 | $151 |
| Fluocinolone Acetonide | 33 | $5,911 | $179 |
| Metronidazole | 40 | $4,255 | $106 |
| Calcipotriene | 16 | $4,188 | $262 |
| Fluorouracil | 19 | $3,183 | $168 |
| Betamethasone Dipropionate | 55 | $2,807 | $51 |
| Acyclovir | 29 | $1,544 | $53 |
| Ciclopirox | 31 | $807 | $26 |
| Clindamycin Phosphate | 13 | $805 | $62 |
| Mometasone Furoate | 14 | $740 | $53 |
| Tretinoin | 11 | $669 | $61 |
| Fluocinonide | 11 | $592 | $54 |
| Valacyclovir | 17 | $520 | $31 |
| Mupirocin | 36 | $497 | $14 |
| Triamcinolone Acetonide | 20 | $458 | $23 |
| Cephalexin | 38 | $440 | $12 |
| Pentoxifylline | 12 | $312 | $26 |
| Silver Sulfadiazine | 15 | $191 | $13 |
| Hydroxyzine | 13 | $168 | $13 |
| Prednisolone Sodium Phosphate | 14 | $168 | $12 |
| Prednisone | 18 | $90 | $5 |
2013: 19 drugs
| Imiquimod | 21 | $8,283 | $394 |
| Desonide | 56 | $4,848 | $87 |
| Desoximetasone | 38 | $4,103 | $108 |
| Fluorouracil | 15 | $3,008 | $201 |
| Metronidazole | 27 | $2,911 | $108 |
| Clobetasol Propionate | 85 | $2,639 | $31 |
| Fluocinolone Acetonide | 32 | $2,502 | $78 |
| Mometasone Furoate | 16 | $1,614 | $101 |
| Betamethasone Dipropionate | 15 | $1,492 | $99 |
| Betamethasone Dipropionate | 22 | $1,136 | $52 |
| Valacyclovir | 20 | $909 | $45 |
| Ciclopirox | 20 | $694 | $35 |
| Doxycycline Hyclate | 14 | $617 | $44 |
| Cephalexin | 40 | $565 | $14 |
| Mupirocin | 38 | $529 | $14 |
| Triamcinolone Acetonide | 18 | $472 | $26 |
| Hydroxyzine | 19 | $391 | $21 |
| Acyclovir | 11 | $197 | $18 |
| Prednisone | 11 | $42 | $4 |
Money from drug and device companies
$173 in 2023
| 2023 | 3 | 14 | None | $173 |
| 2022 | 2 | 3 | None | $44 |
| 2021 | 1 | 1 | None | $11 |
| 2020 | 2 | 2 | None | $28 |
| 2019 | 2 | 2 | None | $29 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Eucrisa | $133 | 12 payments
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| LEO Pharma | Adbry | $13 | 1 payment
|
See all 14 published payments
| Pfizer | Meals · 2023-12-06 | Cibinqo | $9 |
| Pfizer | Meals · 2023-10-10 | Cibinqo | $10 |
| Pfizer | Meals · 2023-07-20 | Eucrisa | $12 |
| Pfizer | Meals · 2023-06-16 | Eucrisa | $10 |
| Pfizer | Meals · 2023-05-09 | Eucrisa | $6 |
| Pfizer | Education · 2023-04-06 | Cibinqo | $15 |
| Pfizer | Meals · 2023-04-06 | Eucrisa | $11 |
| Pfizer | Education · 2023-03-29 | Cibinqo | $15 |
| Pfizer | Meals · 2023-03-17 | Eucrisa | $11 |
| Pfizer | Meals · 2023-02-21 | Eucrisa | $14 |
| Pfizer | Meals · 2023-02-01 | Eucrisa | $6 |
| LEO Pharma | Meals · 2023-01-31 | Adbry | $13 |
| Regeneron Healthcare Solutions | Meals · 2023-01-20 | Dupixent | $27 |
| Pfizer | Meals · 2023-01-13 | Eucrisa | $14 |
See earlier years (2022, 2021, 2020, 2019)
2022: $44
| LEO Pharma | Adbry | $31 | 2 payments
|
| Abbvie | Skyrizi | $13 | 1 payment
|
2021: $11
| Regeneron Healthcare Solutions | Dupixent | $11 | 1 payment
|
2020: $28
| Pfizer | Eucrisa | $16 | 1 payment
|
| LEO Pharma | Enstilar | $11 | 1 payment
|
2019: $29
| Ortho Dermatologics a division of Bausch Health US | Retin-A | $15 | 1 payment
|
| LEO Pharma | Enstilar | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194789628
- Licence
- CA C33449California C33449: Current · expires 2027-05-31
- Trained
- Johns Hopkins University School of Medicine, 1968
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207N00000X (207N00000X); Federal specialty code 207NP0225X (207NP0225X)
- Mailing address
- 177 Bovet Rd Fl 6, Attn: Cd Billing, LLC, San Mateo, CA, 94402
- NPI first listed
- 2006-04-13
- NPI last updated
- 2024-04-16
- NPI record certified
- 2024-04-16
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 725 Welch Rd, Palo Alto, CA, 94304